Sectoral Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Sectoral Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-89,250	Closed	-$2.54M	–	114
2022 Q2	$2.54M	Buy	89,250 +4,250	+5%	+$135K	0.51%	74
2022 Q1	$3M	Sell	85,000 -25,000	-23%	-$838K	0.53%	68
2021 Q4	$4.61M	Buy	+110,000	New	+$4.46M	0.69%	57
2021 Q1	–	Sell	-978,600	Closed	-$27.4M	–	126
2020 Q4	$27.4M	Buy	+978,600	New	+$27.3M	1.93%	18

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Sectoral Asset Management's MRVI Position: Q3 2022 in Review

Sectoral Asset Management sold out of Maravai LifeSciences (MRVI) in Q3 2022, closing a stake of 89,250 shares — an estimated $2.54M sold.

Sectoral Asset Management first reported a position in MRVI in Q4 2020 and held it in 4 quarters. The position peaked at $27.4M in Q4 2020. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2022.

Sectoral Asset Management reported no remaining Maravai LifeSciences position as of Q3 2022 after selling out during the quarter.
Sectoral Asset Management sold 89,250 Maravai LifeSciences shares in Q3 2022, an estimated $2.54M.
Sectoral Asset Management first reported a position in Maravai LifeSciences in Q4 2020 and held it in 4 quarters.
Sectoral Asset Management's Maravai LifeSciences position peaked at $27.4M in Q4 2020.
202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2022.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.